Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease-Reference-Cited by-同舟云学术

Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease

Published:2012-05 Issue:2 Volume:3 Page:58-73
ISSN:1759-1961
Container-title:Clinical and Experimental Neuroimmunology
language:en
Short-container-title:Clin. Exp. Neuroimmunol.

Author:

Fujihara Kazuo,Misu Tatsuro,Nakashima Ichiro¹,Takahashi Toshiyuki,Bradl Monika²,Lassmann Hans²,Takano Rina¹,Nishiyama Shuhei¹,Takai Yoshiki¹,Suzuki Chihiro¹,Sato Douglas¹,Kuroda Hiroshi¹,Nakamura Masashi³,Fujimori Juichi³,Narikawa Koichi⁴,Sato Shigeru⁵,Itoyama Yasuto⁶,Aoki Masashi¹

Affiliation:

1. Department of Neurology; Tohoku University Graduate School of Medicine; Sendai; Japan

2. Center for Brain Research; Medical University Vienna; Vienna; Austria

3. Department of Neurology; Tohoku Welfare Pension Hospital; Sendai; Japan

4. Department of Neurology; National Hospital Organization Sendai Medical Center; Sendai; Japan

5. Department of Neurology; Kohnan Hospital; Sendai; Japan

6. National Center Hosptial; National Center of Neurology and Psychiatry; Tokyo; Japan

Publisher

Wiley

Subject

Neurology (clinical),Immunology and Microbiology (miscellaneous),Immunology,Neuroscience (miscellaneous)

Reference109 articles.

1. Myélite aiguë compliquée de névrite optique;Devic;Bull Med (Paris),1894

2. Devic's neuromyelitis optica: a clinicopathological study of 8 patients;Mandler;Ann Neurol,1993

3. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica;O'Riordan;J Neurol Neurosurg Psychiatry,1996

4. The clinical course of neuromyelitis optica (Devic's syndrome);Wingerchuk;Neurology,1999

5. The spectrum of neuromyelitis optica;Wingerchuk;Lancet Neurol,2007

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuromyelitis optica spectrum disorder safely and successfully treated with satralizumab during pregnancy and breastfeeding: a case report;Frontiers in Neurology;2023-12-15

2. Neuromyelitis optica spectrum disorders (NMOSD) and systemic lupus erythematosus (SLE): Dangerous duo;International Journal of Rheumatic Diseases;2023-11-17

3. Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder;Journal of Neurology, Neurosurgery & Psychiatry;2023-05-23

4. Comparison of OX40 expression in patients with multiple sclerosis and neuromyelitis optica as an approach to diagnosis;Allergy, Asthma & Clinical Immunology;2023-03-10

5. Long-term safety and effectiveness of eculizumab in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a 2-year interim analysis of post-marketing surveillance in Japan;Therapeutic Advances in Neurological Disorders;2023-01